What is the role of allogeneic stem cell transplantation (SCT) in the treatment of acute myeloid leukemia (AML)?

Updated: May 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Most patients younger than 60 years should be evaluated for allogeneic stem cell transplantation (HCT). Exceptions include patients with favorable cytogenetic and molecular markers and those with significant comorbidities. Other options for post-remission therapy include further chemotherapy and, rarely, autologous HCT.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!